A Unique Case of Recurrent Intracranial Extravascular Papillary Endothelial Hyperplasia After Gross Total Resection and Brachytherapy

Munier, Sean M; Bitar, Mireille; Cohen, Michael; Danish, Shabbar F.

doi:10.1016/j.wneu.2018.05.243

Cited by 5 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Histologically neither of our reported cases showed evidence of the lesion being associated with a vessel wall and therefore is deemed to be of the extravascular type. The extravascular form is much rarer (with fewer than 5% of reported cases representing this type) and is most commonly described in the context of complications following intracranial stereotactic radiotherapy 11. An occasional case has been described within the head and neck 12,13.…”

Section: Discussionmentioning

confidence: 99%

Ovarian Extravascular Papillary Endothelial Hyperplasia (Masson Tumor) Mimicking a Primary Gynecologic Malignancy

Sherring

Foot²,

Barton³

et al. 2020

International Journal of Gynecological Pathology

View full text Add to dashboard Cite

Papillary endothelial hyperplasia or Masson tumor most commonly occurs within the extremities and head and neck. It is usually of intravascular type, associated with thrombus formation and organization within a preexisting vessel or vascular malformation, but rarely can be extravascular. We describe the first 2 cases of this extravascular type to occur within the ovary, one of which mimicked malignancy radiologically. This condition is thought to represent a reactive phenomenon with reparative response secondary to thrombosis although with an unclear underlying pathogenesis. The prognosis is generally good, with complete surgical resection usually representing adequate treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

Ovarian Extravascular Papillary Endothelial Hyperplasia (Masson Tumor) Mimicking a Primary Gynecologic Malignancy

Sherring

Foot²,

Barton³

et al. 2020

International Journal of Gynecological Pathology

View full text Add to dashboard Cite

show abstract

“…Some published trials demonstrated that pancreatic cancer cells were sensitive to continuous, lowenergy iodine-125 seed irradiation [43,44] and that the γ-rays released by iodine-125 seeds could lead to cell apoptosis and DNA hypermethylation [45], then reducing tumor volume. Besides, iodine-125 inhibits vascular endothelial hyperplasia and tumor cell growth, prolonging the OS of a patient with malignant tumors [46,47]. Gemcitabine is a kind of pyrimidine analogue and the most important mechanism of action of gemcitabine is the inhibition of DNA synthesis and activity as a ribonucleoside reductase inhibitor, leading to interruption of DNA chains [48,49].…”

Section: Mechanism and Feasibilitymentioning

confidence: 99%

The Efficacy and Safety of Iodine-125 Implantation Combined with Gemcitabine in the Treatment of Advanced Pan- creatic Cancer: A Systematic Review and Meta-analysis

Yan

Wang

et al. 2021

Multidiscip Cancer Investig

View full text Add to dashboard Cite

Introduction: A systematic review and meta-analysis was conducted to assess the efficacy and safety of iodine-125 implantation combined with gemcitabine in the treatment of advanced pancreatic cancer. Methods: PubMed, Chinese National Knowledge Infrastructure database (CNKI), Cochrane Library, Embase, and Wanfang database through Oct 2020 were searched for randomized controlled trials (RCTs) and retrospective studies assessing the efficacy and safety of iodine-125 implantation combined with gemcitabine in the treatment of advanced pancreatic cancer. The main outcome measures included the overall remission [complete response (CR)+partial response (PR)] rate, overall survival (OS), hypofunction of the liver, clinical benefit response (CBR) rate, survival rate, and adverse events. Results: Totally, 19 studies involving 1496 patients were included in the current systematic review and meta-analysis. The pooled results showed that efficacy and safety of patients treated with Iodine-125 combined with gemcitabine were superior to those undergoing gemcitabine alone: overall remission (CR+PR) rate [odds ratio (OR)=3.

show abstract

Transarterial chemoembolisation plus I125 seeds implantation for people with unresectable hepatocellular carcinoma

Yan

Deng

et al. 2022

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

A Unique Case of Recurrent Intracranial Extravascular Papillary Endothelial Hyperplasia After Gross Total Resection and Brachytherapy

Cited by 5 publications

References 17 publications

Ovarian Extravascular Papillary Endothelial Hyperplasia (Masson Tumor) Mimicking a Primary Gynecologic Malignancy

Ovarian Extravascular Papillary Endothelial Hyperplasia (Masson Tumor) Mimicking a Primary Gynecologic Malignancy

The Efficacy and Safety of Iodine-125 Implantation Combined with Gemcitabine in the Treatment of Advanced Pan- creatic Cancer: A Systematic Review and Meta-analysis

Transarterial chemoembolisation plus I125 seeds implantation for people with unresectable hepatocellular carcinoma

Contact Info

Product

Resources

About